IDF has a seed grant program to encourage and support patient-oriented research on primary immunodeficiencies (PI). The intent of the grant is to support well-defined research projects that have a specified benefit for improving the treatment, health, disease management or diagnosis of people with PI. The program is open to applicants currently based in the U.S. and will consist of one-year grants. Award Value: $25,000 - $50,000 (a somewhat higher level of support is available for a few exceptional proposals).